ketanserin has been researched along with Skin Ulcer in 4 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Skin Ulcer: An ULCER of the skin and underlying tissues.
Excerpt | Relevance | Reference |
---|---|---|
"The available data on the use of ketanserin in diabetes mellitus have been reviewed." | 10.16 | Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review. ( Janssens, M; Robertson, MP; Symoens, J, 1991) |
"The use of a 2% ointment formulation of ketanserin, an S2-serotoninergic blocking agent, was investigated in a randomized double-blind clinical trial for its effect on the healing of wounds of patients with decubitus, venous, and ischemic skin ulcers." | 9.06 | Use of topical ketanserin in the treatment of skin ulcers: a double-blind study. ( Cauwenbergh, G; De Beule, K; De Doncker, P; Janssen, H; Janssen, PA; Lapière, CM; Lewi, P; Tytgat, HF, 1989) |
"The available data on the use of ketanserin in diabetes mellitus have been reviewed." | 6.16 | Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review. ( Janssens, M; Robertson, MP; Symoens, J, 1991) |
"The use of a 2% ointment formulation of ketanserin, an S2-serotoninergic blocking agent, was investigated in a randomized double-blind clinical trial for its effect on the healing of wounds of patients with decubitus, venous, and ischemic skin ulcers." | 5.06 | Use of topical ketanserin in the treatment of skin ulcers: a double-blind study. ( Cauwenbergh, G; De Beule, K; De Doncker, P; Janssen, H; Janssen, PA; Lapière, CM; Lewi, P; Tytgat, HF, 1989) |
"Now progressive systemic sclerosis (PSS) is considered a disease of small vessels with which many immunologic alterations are associated." | 1.27 | Ketanserin in the treatment of progressive systemic sclerosis. ( Altomare, GF; Pigatto, PD; Polenghi, MM, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Janssens, M | 1 |
Symoens, J | 1 |
Robertson, MP | 1 |
Rooman, RP | 1 |
Janssen, H | 2 |
Janssen, PA | 1 |
Cauwenbergh, G | 1 |
De Doncker, P | 1 |
De Beule, K | 1 |
Lewi, P | 1 |
Tytgat, HF | 1 |
Lapière, CM | 1 |
Altomare, GF | 1 |
Pigatto, PD | 1 |
Polenghi, MM | 1 |
1 review available for ketanserin and Skin Ulcer
Article | Year |
---|---|
Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetic Angiopathies; Foot Ulcer; Humans; Hypertensi | 1991 |
3 trials available for ketanserin and Skin Ulcer
Article | Year |
---|---|
Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetic Angiopathies; Foot Ulcer; Humans; Hypertensi | 1991 |
Ketanserin promotes wound healing: clinical and preclinical results.
Topics: Aged; Chronic Disease; Double-Blind Method; Female; Granulation Tissue; Humans; Ketanserin; Leg Ulce | 1991 |
Use of topical ketanserin in the treatment of skin ulcers: a double-blind study.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Isch | 1989 |
1 other study available for ketanserin and Skin Ulcer
Article | Year |
---|---|
Ketanserin in the treatment of progressive systemic sclerosis.
Topics: Adult; Female; Fingers; Humans; Ketanserin; Middle Aged; Raynaud Disease; Regional Blood Flow; Scler | 1988 |